Company intelligence / Profile preview

Neuroscience Trials Australia

Parkville, Victoria, Australianeurosciencetrialsaustralia.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

NTA has over two decades of experience managing early through late-phase neuroscience clinical trials for pharmaceutical companies globally. It provides access to key opinion leaders and sites via its relationship with The Florey Institute. No direct clinical results as it does not sponsor drugs itself.

Therapeutic areas: PsychiatryOphthalmologyImmunologyEndocrinologyOncologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeBiologicDeviceCell therapyDiagnostic
Industry: Contract Research Organization

Partnerships

local/international biotech/pharma/device companies/universities/hospitalskey opinion leaders via The Florey Institute network

Beyond the preview

Go deeper on Neuroscience Trials Australia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroscience Trials Australia.

Explore the full profile